Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
11/2007
11/29/2007CA2652484A1 Heterocyclic type cinnamide derivative
11/29/2007CA2652251A1 Compositions of r(+) and s(-) pramipexole and methods for using the same
11/29/2007CA2652117A1 Therapeutic fluoroethyl ureas
11/29/2007CA2651677A1 2-arylpyrazolo[l,5-.alpha.]pyrimidin-3-yl acetamide derivatives as ligands for translocator protein (18 kda)
11/29/2007CA2651607A1 Mirtazapine for the treatment of neuropathic pain
11/29/2007CA2651451A1 Extended release oral multimicroparticle dosage form
11/29/2007CA2651396A1 Urea type cinnamide derivative
11/29/2007CA2649913A1 N-benzoyl- and n-benzylpyrrolidin-3-ylamines as histamine-3 antagonists
11/29/2007CA2649707A1 Substituted pyrazinone derivatives for use as a medicine
11/29/2007CA2647830A1 Central nervous system active fused bicycloheterocycle substituted azabicyclic alkane derivatives
11/29/2007CA2646076A1 3-pyraz0lyl-benzamide-4-ethers, secondary amines and derivatives thereof as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto
11/28/2007EP1860185A1 Screening method
11/28/2007EP1860118A2 Immunoadhesin comprising a glycoprotein VI domain
11/28/2007EP1860113A1 Ectonucleotidase inhibitors
11/28/2007EP1859807A1 Recurrence preventive therapeutic agent for psychostimulant-induced psychosis and schizophrenia
11/28/2007EP1859800A1 Medicament comprising alkyl esters of imidazole carboxylic acid for the treatment of neurodegenerative disorders
11/28/2007EP1859798A1 N-(2-arylethyl) benzylamines as antagonists of the 5-ht6 receptor
11/28/2007EP1859679A1 Protective solution for preventing ischaemia damage
11/28/2007EP1859274A2 Genes involved in neurodegenerative conditions
11/28/2007EP1859041A1 Aprotinin polypeptides for transporting a compound across the blood-brain barrier
11/28/2007EP1858913A2 Mimetic peptides and the use thereof in the form of 20s, 26s and immunoproteasome inhibitors
11/28/2007EP1858912A2 Compounds for reducing aggregation of amyloid beta-peptide
11/28/2007EP1858900A1 Fused thiazole derivatives having affinity for the histamine h3 receptor
11/28/2007EP1858896A1 Diaza-spiro-[4.4]-nonane derivatives as neurokinin (nk1) antagonists
11/28/2007EP1858892A1 Anhydrous ziprasidone mesylate and a process for its preparation
11/28/2007EP1858891A2 Crystalline forms of ziprasidone mesylate
11/28/2007EP1858874A1 (s)-n,n-dimethyl-3-(1-naphthalenyloxy)-3-(2-thienyl) propanamine-di-p-toluoyl-l-tartarate and methods of preparation thereof
11/28/2007EP1858873A2 Process for the purification of duloxetine hydrochloride
11/28/2007EP1858872A1 Derivatives of n-[(4,5-diphenyl-3-alkyl-2-thienyl) methyl] amine (amide, thiourea and urea) as cannabinoid cb1 receptor antagonists
11/28/2007EP1858869A1 Acylated piperidines as glycine transporter inhibitors
11/28/2007EP1858868A1 Compounds
11/28/2007EP1858865A1 Substituted n-sulfonylaminophenylethyl-2-phenoxy acetamide compounds
11/28/2007EP1858862A1 PYRAZINE -2-CARBOXAMIDE DERIVATIVES AS mGluR5 ANTAGONISTS
11/28/2007EP1858859A1 Process for the preparation of optically active (s)-(+)-n,n-dimethyl-3-(1-naphthalenyloxy)-3-(2-thienyl)propanamine
11/28/2007EP1858857A1 Azabicycloalkane derivatives useful as nicotinic acetylcholine receptor agonists
11/28/2007EP1858854A1 Pyridine-2-carboxamide derivatives as mglur5 antagonists
11/28/2007EP1858852A1 Heteroarylsulfonyl stilbenes as 5-ht2a antagonists
11/28/2007EP1858847A1 Stable form i donepezil hydrochloride and process for its preparation and use in pharmaceutical compositions
11/28/2007EP1858520A2 Quinazolinone t-type calcium channel antagonists
11/28/2007EP1858517A2 Pharmaceutical compositions for the treatment and/or prevention of schizophrenia and related diseases
11/28/2007EP1858515A2 Pharmaceutical compositions for the treatment and/or prevention of anxiety disorders
11/28/2007EP1858505A2 Polyacetylen compounds isolated from cussonia
11/28/2007EP1858502A1 Methods and pharmaceutical compositions for the treatment of neurological damage
11/28/2007EP1858498A2 Use of microtubule stabilizing compounds for the treatment of lesions of cns axons
11/28/2007EP1858493A2 Oral drug delivery system
11/28/2007EP1725543B1 4-benzimidazol-2-yl-pyridazine-3-one-derivatives, production and use thereof in medicaments
11/28/2007EP1678177B1 Triaza-spiropiperidine derivatives for use as glyt-1 inhibitors in the treatment of neurological and neuropsychiatric disorders
11/28/2007EP1667975B1 A polymorphic form of 3-phenylsulfonyl-8-piperazin-1-yl-quinoline
11/28/2007EP1635851A4 Methods for treating cognitive impairment and improving cognition
11/28/2007EP1553909A4 Quick dissolve compositions and tablets based thereon
11/28/2007EP1458395B1 Medical use of gsk3-inhibiting oxindole derivatives
11/28/2007EP1448201B1 N-(indolcarbonyl-)piperazine derivatives for the treatment of obesity
11/28/2007EP1406613B1 Organic nitratederivatives for the treatment of atherosclerosis and vascular diseases
11/28/2007EP1399430B1 Oxazol/ thiazol-derivatives activators of the hppar-alpha receptor
11/28/2007EP1373257B1 Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases
11/28/2007EP1333832B1 Novel uses of combined 5-ht1a agonists and serotonin reuptake inhibitors
11/28/2007EP1006794B1 A method for treating or preventing alzheimer's disease
11/28/2007EP0983222B1 Pharmaceutical agents for the treatment of cerebral amyloidosis
11/28/2007EP0937103B1 Compounds and methods for modulating cell adhesion
11/28/2007EP0879054B1 Application of pyrrolidine derivatives to the preparation of medicaments intended to the treatment of drug abuse
11/28/2007CN101080421A Antibody and utilization of the same
11/28/2007CN101080231A Method for preparing galantamine hydrobromide
11/28/2007CN101078013A Identification and application of neurotrophy factor BDNF and NT-3 signal path new component Dok5
11/28/2007CN101078012A 干细胞分化 Stem cell differentiation
11/28/2007CN101077888A Polyethylene glycol modified neurotoxin, preparation method and use thereof
11/28/2007CN101077413A Neuropeptide compound preparation for detoxification and addiction-removing
11/28/2007CN101077407A Medicine for treating depression caused by simple emotion factor
11/28/2007CN101077399A Process for producing traditional Chinese medicine 'naolijing'
11/28/2007CN101077396A Method for treating chronic insomnia
11/28/2007CN101077395A Method for treating temporary insomnia
11/28/2007CN101077373A Preparation for treating hepatic encephalopathy and preparation method thereof
11/28/2007CN101077370A Method for treating short-term insomnia
11/28/2007CN101077365A Radix paeoniae alba extraction for improving sleeping duration time and quality
11/28/2007CN101077357A Application for extration of glossy ganoderma in preparing medicine and health products for treating and improving depression symptoms a variety of causes resulting sleep disorder
11/28/2007CN101077178A Nutritive health-care food and its making method
11/28/2007CN101077154A Drunkenness-dispelling and liver-protecting bean product and its manufacturing method
11/28/2007CN101077111A Agastache mate tea
11/28/2007CN101077110A Health-care tea and its making method
11/28/2007CN101077106A Reposing and depression and anxiety-inhibiting tea
11/28/2007CN100351259C Sulfur-containing phospholipid derivatives
11/28/2007CN100351253C Pyrrolo [2,3-d] pyrimidine compounds as immunosuppressive agents
11/28/2007CN100351250C Nobel compounds having selective inhibiting effect at GSK3
11/28/2007CN100351245C Oxa- and thiadiazoles and their use as metalloproteinase inhibitors
11/28/2007CN100351244C Bis-aromatic alkanols
11/28/2007CN100351239C Pyrimidine derivatives and their use as CB2 modulators
11/28/2007CN100351237C Novel hererocyclic compound and preparation thereof and medicine composition containing same and use thereof in medicine
11/28/2007CN100351236C 1-heterocyclylalkyl-3-sulfonyl-indole or -indazole derivatives as 5-hydroxytryptamine-6 ligands
11/28/2007CN100351225C Symmetrel derivatives and synthesis method thereof and their use as neuron damage protective agent
11/28/2007CN100350970C 因子 Factor
11/28/2007CN100350942C Insomnia treating medicinal wine
11/28/2007CN100350937C Traditional Chinese medicinal composition for treating insomnia and its preparing process
11/27/2007US7301023 Immunosuppressants; grafting of organs; rheumatic diseases
11/27/2007US7300952 NF-κb inhibitors
11/27/2007US7300951 Fluoro- and trifluoroalkyl-containing heterocyclic sulfonamide inhibitors of beta amyloid production and derivatives thereof
11/27/2007US7300950 Pyrazole derivatives, their preparation and their use in pharmaceuticals
11/27/2007US7300945 For therapy of of certain central nervous system (CNS) diseases, anxiety, depression, a sleep disorder, schizophrenia, or attention deficit-hyperactivity disorder
11/27/2007US7300944 Alzheimer's disease, bipolar disorder, diabetes, dementia, stroke, schizophrenia, depression, hair loss, cancer
11/27/2007US7300943 Pyrazolo[3,4-b]pyridin-6-ones which are inhibitors of cyclin-dependent protein kinases and glycogen synthase kinase; diabetes, dementia, Alzheimer's disease, stroke, schizophrenia, alopecia, and cancer; antiasthmatics, angiogenesis inhibitors; antiproliferative, neuroprotective and neuroleptic agents
11/27/2007US7300941 Non-imidazole compounds
11/27/2007US7300937 Derivatives of cyano-aryl (or cyanoheteroaryl)-carbonyl-piperazinyl-pyrimidines, their preparation and application as medication
1 ... 739 740 741 742 743 744 745 746 747 748 749 750 751 752 753 754 755 756 757 758 759 ... 1833